[1]
J. O. . Dawood and A. . Abu-Raghif, “Moxifloxacin’s Therapeutic Effects in AA-Induced Colitis: Anti-Inflammatory Action through NF-κB Pathway Inhibition, Including TNF-α Pathway and Downstream Inflammatory Processes ”, J. Contemp. Med. Sci., vol. 9, no. 4, pp. 239–244, Aug. 2023.